REGN

Regeneron Pharmaceuticals
REGN

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$55.92B
EV
$41.00B
Shares Outstanding
105.67M
Beta
0.31

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$727.21
P/E 2025E
14.93x
P/Revenue 2025E
4.15x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Regeneron Pharmaceuticals, Inc.

gainify
REGN

Regeneron Pharmaceuticals, Inc.

REGN

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company’s products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; m...

Sector

Healthcare

Industry

Biotechnology

CEO

Schleifer, Leonard

Employees

15,158

IPO Date

1991-04-02

Headquarters

777 Old Saw Mill River Road, Tarrytown, New York, 10591-6707, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.